Cargando…
Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration
INTRODUCTION: This study compared the number of, and expenditures on, first-line intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections between patients who were treated with aflibercept or ranibizumab for wet age-related macular degeneration (AMD). METHODS: This was a retrospec...
Autores principales: | Johnston, Stephen S., Wilson, Kathleen, Huang, Alice, Smith, David, Varker, Helen, Turpcu, Adam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906738/ https://www.ncbi.nlm.nih.gov/pubmed/24310208 http://dx.doi.org/10.1007/s12325-013-0078-4 |
Ejemplares similares
-
Erratum to: Retrospective Analysis of First-Line Anti-Vascular Endothelial Growth Factor Treatment Patterns in Wet Age-Related Macular Degeneration
por: Johnston, Stephen S., et al.
Publicado: (2014) -
Real-World Injection Frequency and Cost of Ranibizumab and Aflibercept for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
por: Kiss, Szilárd, et al.
Publicado: (2020) -
The comparative effectiveness and cost-effectiveness of ranibizumab for neovascular macular degeneration revisited
por: Brown, Gary C., et al.
Publicado: (2017) -
Patient Preferences for Anti-Vascular Endothelial Growth Factor Treatment for Wet Age-Related Macular Degeneration in Japan: A Discrete Choice Experiment
por: Joko, Takeshi, et al.
Publicado: (2020) -
Imaging of Wet Age-Related Macular Degeneration
por: Kenan, Damer
Publicado: (2016)